Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker ALMU
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Sep 21, 2026 | Jonathan Klamkin Chief Executive Officer, Director | ALMU Aeluma, Inc. | Sale | 100,000 | $13.35 | $1.3M Sale | Form 4 ↗ |
| Aug 27, 2026 | Steven Denbaars Director | ALMU Aeluma, Inc. | Sale | 12,500 | $13.82 | $172.8K Sale | Form 4/A ↗ |
| Aug 26, 2026 | Steven Denbaars Director | ALMU Aeluma, Inc. | Sale | 12,500 | $13.84 | $173.0K Sale | Form 4/A ↗ |
| Aug 3, 2026 | Jonathan Klamkin Chief Executive Officer, Director | ALMU Aeluma, Inc. | Sale | 15,810 | $16.85 | $266.4K Sale | Form 4 ↗ |
| Aug 3, 2026 | Jonathan Klamkin Chief Executive Officer, Director | ALMU Aeluma, Inc. | Sale | 4,190 | $16.29 | $68.3K Sale | Form 4 ↗ |
| Jul 1, 2026 | Jonathan Klamkin Chief Executive Officer, Director | ALMU Aeluma, Inc. | Sale | 100 | $21.56 | $2,156 Sale | Form 4 ↗ |
| Jul 1, 2026 | Jonathan Klamkin Chief Executive Officer, Director | ALMU Aeluma, Inc. | Sale | 19,900 | $21.08 | $419.5K Sale | Form 4 ↗ |
| Jun 1, 2026 | Jonathan Klamkin Chief Executive Officer, Director | ALMU Aeluma, Inc. | Sale | 8,200 | $26.25 | $215.3K Sale | Form 4 ↗ |
| Jun 1, 2026 | Jonathan Klamkin Chief Executive Officer, Director | ALMU Aeluma, Inc. | Sale | 1,600 | $25.12 | $40.2K Sale | Form 4 ↗ |
| Jun 1, 2026 | Jonathan Klamkin Chief Executive Officer, Director | ALMU Aeluma, Inc. | Sale | 7,900 | $24.39 | $192.7K Sale | Form 4 ↗ |
| Jun 1, 2026 | Jonathan Klamkin Chief Executive Officer, Director | ALMU Aeluma, Inc. | Sale | 1,400 | $23.32 | $32.6K Sale | Form 4 ↗ |
| Jun 1, 2026 | Jonathan Klamkin Chief Executive Officer, Director | ALMU Aeluma, Inc. | Sale | 900 | $22.19 | $20.0K Sale | Form 4 ↗ |
| May 20, 2026 | Steven Denbaars Director | ALMU Aeluma, Inc. | Sale | 942 | $21.30 | $20.1K Sale | Form 4 ↗ |
| May 20, 2026 | Steven Denbaars Director | ALMU Aeluma, Inc. | Sale | 11,558 | $20.40 | $235.8K Sale | Form 4 ↗ |
| May 19, 2026 | Steven Denbaars Director | ALMU Aeluma, Inc. | Sale | 5,085 | $20.61 | $104.8K Sale | Form 4 ↗ |
| May 19, 2026 | Steven Denbaars Director | ALMU Aeluma, Inc. | Sale | 7,415 | $19.56 | $145.0K Sale | Form 4 ↗ |
| May 1, 2026 | Jonathan Klamkin Chief Executive Officer, Director | ALMU Aeluma, Inc. | Sale | 676 | $25.71 | $17.4K Sale | Form 4 ↗ |
| May 1, 2026 | Jonathan Klamkin Chief Executive Officer, Director | ALMU Aeluma, Inc. | Sale | 15,024 | $25.15 | $377.9K Sale | Form 4 ↗ |
| May 1, 2026 | Jonathan Klamkin Chief Executive Officer, Director | ALMU Aeluma, Inc. | Sale | 4,300 | $24.20 | $104.1K Sale | Form 4 ↗ |
| Apr 1, 2026 | Jonathan Klamkin Chief Executive Officer, Director | ALMU Aeluma, Inc. | Sale | 20,000 | $13.10 | $262.0K Sale | Form 4 ↗ |
| Mar 4, 2026 | Jonathan Klamkin Chief Executive Officer, Director, 10%… | ALMU Aeluma, Inc. | Sale | 21,794 | $18.41 | $401.2K Sale | Form 4 ↗ |
| Mar 4, 2026 | Jonathan Klamkin Chief Executive Officer, Director, 10%… | ALMU Aeluma, Inc. | Sale | 28,206 | $17.77 | $501.2K Sale | Form 4 ↗ |
| Feb 26, 2026 | Steven Denbaars Director | ALMU Aeluma, Inc. | Sale | 12,500 | $15.85 | $198.1K Sale | Form 4 ↗ |
| Feb 25, 2026 | Steven Denbaars Director | ALMU Aeluma, Inc. | Sale | 12,500 | $17.58 | $219.8K Sale | Form 4 ↗ |
| Feb 4, 2026 | Mark N. Tompkins | ALMU Aeluma, Inc. | Sale | 5,956 | $15.12 | $90.1K Sale | Form 4 ↗ |
| Feb 4, 2026 | Mark N. Tompkins | ALMU Aeluma, Inc. | Sale | 28,544 | $14.63 | $417.6K Sale | Form 4 ↗ |
| Feb 2, 2026 | Mark N. Tompkins 10% owner | ALMU Aeluma, Inc. | Sale | 37,500 | $15.74 | $590.3K Sale | Form 4 ↗ |
| Jan 30, 2026 | Mark N. Tompkins 10% owner | ALMU Aeluma, Inc. | Sale | 908 | $16.79 | $15.2K Sale | Form 4 ↗ |
| Jan 30, 2026 | Mark N. Tompkins 10% owner | ALMU Aeluma, Inc. | Sale | 24,092 | $15.88 | $382.6K Sale | Form 4 ↗ |
| Jan 29, 2026 | Mark N. Tompkins 10% owner | ALMU Aeluma, Inc. | Sale | 5,203 | $17.16 | $89.3K Sale | Form 4 ↗ |
| Jan 29, 2026 | Mark N. Tompkins 10% owner | ALMU Aeluma, Inc. | Sale | 27,297 | $16.75 | $457.2K Sale | Form 4 ↗ |
| Jan 22, 2026 | Mark N. Tompkins 10% owner | ALMU Aeluma, Inc. | Sale | 962 | $18.81 | $18.1K Sale | Form 4 ↗ |
| Jan 22, 2026 | Mark N. Tompkins 10% owner | ALMU Aeluma, Inc. | Sale | 29,038 | $18.05 | $524.1K Sale | Form 4 ↗ |
| Jan 21, 2026 | Mark N. Tompkins 10% owner | ALMU Aeluma, Inc. | Sale | 10 | $21.24 | $212 Sale | Form 4 ↗ |
| Jan 21, 2026 | Mark N. Tompkins 10% owner | ALMU Aeluma, Inc. | Sale | 1,715 | $20.44 | $35.1K Sale | Form 4 ↗ |
| Jan 21, 2026 | Mark N. Tompkins 10% owner | ALMU Aeluma, Inc. | Sale | 12,947 | $19.30 | $249.9K Sale | Form 4 ↗ |
| Jan 21, 2026 | Mark N. Tompkins 10% owner | ALMU Aeluma, Inc. | Sale | 30,328 | $18.52 | $561.7K Sale | Form 4 ↗ |
| Jan 20, 2026 | Mark N. Tompkins 10% owner | ALMU Aeluma, Inc. | Sale | 888 | $21.58 | $19.2K Sale | Form 4 ↗ |
| Jan 20, 2026 | Mark N. Tompkins 10% owner | ALMU Aeluma, Inc. | Sale | 29,112 | $20.66 | $601.5K Sale | Form 4 ↗ |
| Dec 26, 2025 | Mark N. Tompkins 10% owner | ALMU Aeluma, Inc. | Sale | 2,662 | $18.39 | $49.0K Sale | Form 4 ↗ |
| Dec 26, 2025 | Mark N. Tompkins 10% owner | ALMU Aeluma, Inc. | Sale | 20,368 | $18.01 | $366.8K Sale | Form 4 ↗ |
| Dec 26, 2025 | Mark N. Tompkins 10% owner | ALMU Aeluma, Inc. | Sale | 6,970 | $16.91 | $117.9K Sale | Form 4 ↗ |
| Dec 24, 2025 | Mark N. Tompkins 10% owner | ALMU Aeluma, Inc. | Sale | 15,000 | $16.05 | $240.8K Sale | Form 4 ↗ |
| Dec 23, 2025 | Mark N. Tompkins 10% owner | ALMU Aeluma, Inc. | Sale | 15,000 | $14.87 | $223.1K Sale | Form 4 ↗ |
| Dec 22, 2025 | Mark N. Tompkins 10% owner | ALMU Aeluma, Inc. | Sale | 35,000 | $14.83 | $519.0K Sale | Form 4 ↗ |
| Dec 19, 2025 | Mark N. Tompkins 10% owner | ALMU Aeluma, Inc. | Sale | 30,000 | $14.70 | $441.0K Sale | Form 4 ↗ |
| Dec 18, 2025 | Mark N. Tompkins 10% owner | ALMU Aeluma, Inc. | Sale | 20,000 | $14.37 | $287.4K Sale | Form 4 ↗ |
| Dec 10, 2025 | Mark N. Tompkins 10% owner | ALMU Aeluma, Inc. | Sale | 20,000 | $17.49 | $349.8K Sale | Form 4 ↗ |
| Dec 9, 2025 | Mark N. Tompkins 10% owner | ALMU Aeluma, Inc. | Sale | 19,139 | $17.06 | $326.5K Sale | Form 4 ↗ |
| Dec 9, 2025 | Mark N. Tompkins 10% owner | ALMU Aeluma, Inc. | Sale | 10,861 | $16.39 | $178.0K Sale | Form 4 ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 5:24 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances